Camp4 Therapeutics Corp 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001628280-26-032146
- Form type
- 10-Q
- CIK
- 0001736730
- Primary document
- https://www.sec.gov/Archives/edgar/data/1736730/000162828026032146/camp-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Camp4 Therapeutics Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $1.3M | - | - |
| Operating Income | $-13.1M | - | - |
| Net Income | $-18.3M | - | - |
| Eps Basic | -0.32 | - | - |
| Eps Diluted | -0.32 | - | - |
| Cash And Equivalents | $99.2M | - | - |
| Total Assets | $105.5M | - | - |
| Total Liabilities | $74.6M | - | - |
| Shareholders Equity | $30.9M | - | - |
| Operating Cash Flow | $-11.0M | - | - |
| Capital Expenditures | $0 | - | - |